Mirela Delibegovic - 'The role of Protein Tyrosine Phosphatase 1B (PTP-1B) in cardiometabolic diseases'
11:00am - 2:00pm /
Wednesday 14th October 2026
/ Venue: Physiology Seminar Room Nuffield Wing
Type: Seminar /
Category: Department
/ Series: Institute of Systems, Molecular and Integrative Biology
- ISMIB Seminar Team
- Suitable for: All are welcome
- Admission: Free to attend
Add this event to my calendar
Click on "Create a calendar file" and your browser will download a .ics file for this event.
Microsoft Outlook: Download the file, double-click it to open it in Outlook, then click on "Save & Close" to save it to your calendar. If that doesn't work go into Outlook, click on the File tab, then on Open & Export, then Open Calendar. Select your .ics file then click on "Save & Close".
Google Calendar: download the file, then go into your calendar. On the left where it says "Other calendars" click on the arrow icon and then click on Import calendar. Click on Browse and select the .ics file, then click on Import.
Apple Calendar: The file may open automatically with an option to save it to your calendar. If not, download the file, then you can either drag it to Calendar or import the file by going to File >Import > Import and choosing the .ics file.
Professor Mirela Delibegovic is the Regius Chair of Physiology at the University of Aberdeen. She is also the founding Director of Aberdeen Cardiovascular and Diabetes Centre, and for the past 25+ years has focused on the role of protein tyrosine phosphatases in obesity and diabetes, with particular emphasis on co-morbidities such as atherosclerosis and cardiovascular disease, diabetic nephropathy and retinopathy and metabolic dysfunction-associated steatotic liver disease (MASLD).
In 2026, she co-founded Miranim Bio, using RNAi targeted therapeutics for MASLD treatment. She has served as Chair of the British Heart Foundation project grants committee; Chair/Vice-Chair roles of Diabetes UK main/fellowships committees and MRC Population and Systems Medicine Board. Mirela is a Fellow of the Royal Society of Edinburgh (FRSE) and an Elected Corresponding Member of the International Academy of Sciences and Arts Bosnia and Herzegovina. She is passionate about career development of staff and students, public engagement in research, academia/industry collaborations and knowledge exchange.
In her lecture, Professor Delibegovic will talk about her lab’s work on PTP1B and its role in cardiometabolic diseases. She will discuss cell-type specific roles in lipid and glucose homeostasis, with emphasis on translational aspects of PTP1B inhibitors in atherosclerosis.
In 2026, she co-founded Miranim Bio, using RNAi targeted therapeutics for MASLD treatment. She has served as Chair of the British Heart Foundation project grants committee; Chair/Vice-Chair roles of Diabetes UK main/fellowships committees and MRC Population and Systems Medicine Board. Mirela is a Fellow of the Royal Society of Edinburgh (FRSE) and an Elected Corresponding Member of the International Academy of Sciences and Arts Bosnia and Herzegovina. She is passionate about career development of staff and students, public engagement in research, academia/industry collaborations and knowledge exchange.
In her lecture, Professor Delibegovic will talk about her lab’s work on PTP1B and its role in cardiometabolic diseases. She will discuss cell-type specific roles in lipid and glucose homeostasis, with emphasis on translational aspects of PTP1B inhibitors in atherosclerosis.